HUP9902415A2 - Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására - Google Patents
Azonnal felszabaduló szilárd beadási formák és eljárás azok előállításáraInfo
- Publication number
- HUP9902415A2 HUP9902415A2 HU9902415A HUP9902415A HUP9902415A2 HU P9902415 A2 HUP9902415 A2 HU P9902415A2 HU 9902415 A HU9902415 A HU 9902415A HU P9902415 A HUP9902415 A HU P9902415A HU P9902415 A2 HUP9902415 A2 HU P9902415A2
- Authority
- HU
- Hungary
- Prior art keywords
- administration
- producing
- same
- release forms
- solid instant
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
A találmány őlyan szilárd, azőnnal felszabadűló beadási főrmákra (IR-beadási főrmák) vőnatkőzik, amelyek őlyan terápiás hatóanyagőkat vagyhatóanyag-kőncentrátűmőkat tartalmaznak, különösen nűkleőzidőklipidkőnjűgátűmait főglalják magűkban, amelyek gélképzőtűlajdőnságőkat műtatnak vizes közegekben. A találmány kiterjed ezekelőállítására alkalmas eljárásra is. ŕ
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19602757A DE19602757A1 (de) | 1996-01-26 | 1996-01-26 | Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung |
PCT/EP1997/000329 WO1997026867A2 (de) | 1996-01-26 | 1997-01-24 | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9902415A2 true HUP9902415A2 (hu) | 1999-11-29 |
HUP9902415A3 HUP9902415A3 (en) | 1999-12-28 |
HU224953B1 HU224953B1 (en) | 2006-04-28 |
Family
ID=7783738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9902415A HU224953B1 (en) | 1996-01-26 | 1997-01-24 | Solid instant-release forms of administration and process for producing the same |
Country Status (21)
Country | Link |
---|---|
US (1) | US6521262B2 (hu) |
EP (1) | EP0877605B1 (hu) |
JP (1) | JP2000506512A (hu) |
KR (1) | KR19990082039A (hu) |
CN (1) | CN1214629A (hu) |
AT (1) | ATE226065T1 (hu) |
AU (1) | AU717456B2 (hu) |
BR (1) | BR9707083A (hu) |
CA (1) | CA2243964A1 (hu) |
CZ (1) | CZ298897B6 (hu) |
DE (2) | DE19602757A1 (hu) |
ES (1) | ES2184987T3 (hu) |
HU (1) | HU224953B1 (hu) |
IL (1) | IL125474A (hu) |
MX (1) | MX9805939A (hu) |
NO (1) | NO323625B1 (hu) |
NZ (1) | NZ331051A (hu) |
PL (1) | PL328157A1 (hu) |
RU (1) | RU2175547C2 (hu) |
WO (1) | WO1997026867A2 (hu) |
ZA (1) | ZA97596B (hu) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2241342C (en) * | 1998-06-15 | 2000-02-08 | Bernard Charles Sherman | Pharmaceutical tablets comprising an nsaid and a prostaglandin |
AT413647B (de) * | 1998-11-26 | 2006-04-15 | Sandoz Ag | Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten |
DE10209822A1 (de) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
RU2338753C2 (ru) * | 2002-03-26 | 2008-11-20 | Новартис Вэксинес Энд Дайэгностикс С.Р.Л. | Модифицированные сахариды, имеющие улучшенную стабильность в воде |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
US7094545B2 (en) | 2003-04-30 | 2006-08-22 | Ferring Bv | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
CN1826099B (zh) * | 2003-07-25 | 2010-06-09 | 凡林有限公司 | 固体剂型药物组合物及其制造方法 |
DE60301351T2 (de) * | 2003-07-25 | 2006-01-19 | Ferring B.V. | Pharmazeutische Desmopressin-Zubereitung als feste Darreichungsform und Methode zu ihrer Herstellung |
GB0323103D0 (en) * | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
US7018653B2 (en) * | 2003-12-29 | 2006-03-28 | Ferring B.V. | Method for preparing solid dosage form of desmopressin |
AU2005321239B2 (en) | 2004-12-30 | 2009-02-12 | Medivir Ab | Compounds useful in the treatment of HIV |
RU2311916C2 (ru) * | 2005-09-27 | 2007-12-10 | Галина Михайловна Сафонова | Средство, обладающее антианемическим, иммуномодулирующим, адаптогенным действием (варианты) |
DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4164560A (en) * | 1977-01-05 | 1979-08-14 | Folkman Moses J | Systems for the controlled release of macromolecules |
US4283394A (en) * | 1979-08-06 | 1981-08-11 | Research Corporation | Cytotoxic nucleoside-corticosteroid phosphodiesters |
US4622392A (en) * | 1984-06-21 | 1986-11-11 | Health Research Inc. (Roswell Park Division) | Thiophospholipid conjugates of antitumor agents |
US4605551A (en) * | 1984-11-30 | 1986-08-12 | William H. Rorer, Inc. | Dry oil coated antacid process |
US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
US4999189A (en) | 1988-11-14 | 1991-03-12 | Schering Corporation | Sustained release oral suspensions |
SE9003902D0 (sv) * | 1990-12-07 | 1990-12-07 | Astra Ab | Solid dosage forms of a drug |
DE4026265A1 (de) | 1990-08-20 | 1992-02-27 | Boehringer Mannheim Gmbh | Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel |
-
1996
- 1996-01-26 DE DE19602757A patent/DE19602757A1/de not_active Withdrawn
-
1997
- 1997-01-24 IL IL12547497A patent/IL125474A/en not_active IP Right Cessation
- 1997-01-24 DE DE59708495T patent/DE59708495D1/de not_active Expired - Fee Related
- 1997-01-24 AT AT97902218T patent/ATE226065T1/de not_active IP Right Cessation
- 1997-01-24 RU RU98116057/14A patent/RU2175547C2/ru not_active IP Right Cessation
- 1997-01-24 CA CA002243964A patent/CA2243964A1/en not_active Abandoned
- 1997-01-24 JP JP9526555A patent/JP2000506512A/ja not_active Ceased
- 1997-01-24 NZ NZ331051A patent/NZ331051A/xx unknown
- 1997-01-24 US US09/117,170 patent/US6521262B2/en not_active Expired - Fee Related
- 1997-01-24 BR BR9707083A patent/BR9707083A/pt active Search and Examination
- 1997-01-24 CN CN97193302A patent/CN1214629A/zh active Pending
- 1997-01-24 WO PCT/EP1997/000329 patent/WO1997026867A2/de active IP Right Grant
- 1997-01-24 PL PL97328157A patent/PL328157A1/xx unknown
- 1997-01-24 ES ES97902218T patent/ES2184987T3/es not_active Expired - Lifetime
- 1997-01-24 CZ CZ0232098A patent/CZ298897B6/cs not_active IP Right Cessation
- 1997-01-24 AU AU15948/97A patent/AU717456B2/en not_active Ceased
- 1997-01-24 HU HU9902415A patent/HU224953B1/hu not_active IP Right Cessation
- 1997-01-24 KR KR1019980705759A patent/KR19990082039A/ko not_active Withdrawn
- 1997-01-24 ZA ZA97596A patent/ZA97596B/xx unknown
- 1997-01-24 EP EP97902218A patent/EP0877605B1/de not_active Expired - Lifetime
-
1998
- 1998-07-23 MX MX9805939A patent/MX9805939A/es not_active IP Right Cessation
- 1998-07-24 NO NO19983437A patent/NO323625B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
KR19990082039A (ko) | 1999-11-15 |
WO1997026867A2 (de) | 1997-07-31 |
ES2184987T3 (es) | 2003-04-16 |
IL125474A (en) | 2001-12-23 |
WO1997026867A3 (de) | 1997-09-25 |
MX9805939A (es) | 1998-11-30 |
DE19602757A1 (de) | 1997-07-31 |
HUP9902415A3 (en) | 1999-12-28 |
AU717456B2 (en) | 2000-03-23 |
CA2243964A1 (en) | 1997-07-31 |
NO323625B1 (no) | 2007-06-18 |
HU224953B1 (en) | 2006-04-28 |
JP2000506512A (ja) | 2000-05-30 |
CN1214629A (zh) | 1999-04-21 |
NZ331051A (en) | 2000-01-28 |
PL328157A1 (en) | 1999-01-18 |
CZ232098A3 (cs) | 1998-10-14 |
NO983437L (no) | 1998-09-28 |
US20020122817A1 (en) | 2002-09-05 |
CZ298897B6 (cs) | 2008-03-05 |
AU1594897A (en) | 1997-08-20 |
ZA97596B (en) | 1998-07-24 |
EP0877605B1 (de) | 2002-10-16 |
BR9707083A (pt) | 1999-03-23 |
EP0877605A2 (de) | 1998-11-18 |
DE59708495D1 (de) | 2002-11-21 |
IL125474A0 (en) | 1999-03-12 |
US6521262B2 (en) | 2003-02-18 |
RU2175547C2 (ru) | 2001-11-10 |
NO983437D0 (no) | 1998-07-24 |
ATE226065T1 (de) | 2002-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0693281A3 (en) | Pharmaceutical preparations containing fluoxetine | |
AU6279996A (en) | Methods of delivering materials into the skin, and compositions used therein | |
CA2219502A1 (en) | Methods and formulations for modulating the human sexual response | |
GR1002451B (el) | Αντιφλεγμονωδεις συνθεσεις που εχουν ως βαση ενεργα συστατικα ορισμενων βοτανων χρησιμοποιουμενες για σκοπους ιατρικους και κτηνιατρικους, και μεθοδοι παρασκευης φαρμακων και σκευασματων για τους παραπανω σκοπους. | |
BG103552A (en) | Therapeutical forms | |
HUP9902415A2 (hu) | Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására | |
MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
MX9602973A (es) | Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida. | |
IL109534A0 (en) | Pour-on formulations containing polymeric material, glycols and glycerides and a process for their preparation | |
BR9509975A (pt) | Formulação farmacêutica | |
NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
BG105275A (en) | Tan-1057 derivatives | |
MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
CA2340734A1 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
GEP20022751B (en) | Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water | |
IL118218A (en) | Pharmaceutical compositions containing sarcodictyins | |
HUP9902032A2 (hu) | Peszticid készítmény | |
MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
EP0373771A3 (en) | New pharmaceutical uses for cystatins | |
CA2091134A1 (en) | Therapeutic agent for threatened abortion | |
IE870577L (en) | Topical amide preparation | |
CA2429793A1 (en) | Interferon therapeutic effect enhancer | |
FR2437832A1 (fr) | Medicament a base de p-tolyl diiodomethylsulfone utile notamment pour le traitement des infections cutanees provoquees par les levures et les champignons |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |